Novacyt Announces Proposed Acquisition of Primer Design Ltd

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has entered into a definitive agreement to acquire the entire share capital of Primer Design Ltd, a profitable and rapidly growing UK molecular diagnostics company. Download press release

Visit Page

Novacyt Revenues Full Year 2015

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its unaudited revenues for the full year to December 2015. Download press release

Visit Page